Insight

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Photo from Triantafyllos Stylianopoulos/LinkedIn

Apr 9, 2024, 13:03

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Triantafyllos Stylianopoulos, Associate Professor at the University of Cyprus, Head of Cancer Biophysics Lab, made the following post on LinkedIn:

”Our new article in AACR Journals Clinical Cancer Research for the role of the mast cells in reprogramming the tumor micro-environment! Stabilizing their function with the anti-histamine ketotifen can improve immunotherapy in sarcomas. Early data from our ongoing clinical trial of ketotifen are presented!
This research was supported by the European Research Council (ERC).”

Read further.
Source: Triantafyllos Stylianopoulos/LinkedIn

AACR Journals Clinical Cancer Research cancer Cancer Biophysics Lab clinical trial ERC European Research Council immunotherapy ketotifen OncoDaily Oncology sarcoma Triantafyllos Stylianopoulos tumor micro-environment University of Cyprus

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage